Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

This study has been completed.
Information provided by (Responsible Party):
Kyowa Hakko Kirin Company, Limited Identifier:
First received: August 14, 2006
Last updated: August 23, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)